Transaction · 0001437749-26-029965

Schoenberg Mark

Schoenberg Mark, CMO, reported an open-market or private sale at UroGen Pharma Ltd. involving 871.000000 shares for an estimated $37383.32. Reported holdings after the transaction were 59882.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCMO
URGNUroGen Pharma Ltd.
Trade date
Sep 08, 2026
Filing date
Sep 09, 2026
View on SEC Insider profile
Estimated value-$37.3kShares × reported price
Shares traded871$42.92 per share
Holdings after59.8kDirect
% of reported position traded1.43%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 60,753 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

URGN price since this filing

Daily closing prices, with the filing date and available return windows
URGN · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +4.4%1w ago -3.6%1d ago -2.0%
Returns since7d -3.4%30d -17.8%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001437749-26-029965
Ordinary Shares
Transaction date
Sep 08, 2026
Filed Sep 09, 2026, 06:37 PM · 1d delay
Shares
871 sh
$42.92 per share
Estimated value
-$37.3k
Computed from shares × price
Holdings after
59,882 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Repeat Seller
Filing-only score

+10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

  2. F2

    Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

  3. F3

    The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.

Original filing · 0001437749-26-029965
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

URGN